Full Press Release Details
SOUTH SAN FRANCISCO and SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in the first half of September:
Citi’s 2023 18th Annual BioPharma Conference – Participating in a targeted oncology panel on Wednesday, September 6, 2023, at 1:00 p.m. ET
Wells Fargo 2023 Healthcare Conference – Participating in a fireside chat on Thursday, September 7, 2023, at 11:00 a.m. ET
H.C. Wainwright 25th Annual Global Investment Conference – Presenting company overview on Monday, September 11, 2023, at 12:30 p.m. ET
Baird 2023 Global Healthcare Conference – Participating in a fireside chat on Tuesday, September 12, 2023, at 2:35 p.m. ET
Webcasts of the panel discussion and presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer